DERMAX

Welcome to the Brand page for “DERMAX”, which is offered here for Transdermal and topical pharmaceutical preparations for humans and animals for the treatment of cardiovascular, viral, bacterial, fungal, inflammatory, circulatory, respiratory, bone, neoplastic, malignant, allergic, convulsant, hypertensive, pain, parasitic, stomach, central nervous system, peripheral nervous system, psychotic, glycemic, muscle or a brain disorder or disease;human and animal transdermal and topical pharmaceutical drug research and development services;.

Its status is currently believed to be active. Its class is unavailable. “DERMAX” is believed to be currently owned by “TransForm Pharmaceuticals, Inc.”


Owner:
TRANSFORM PHARMACEUTICALS, INC.
Owner Details
Description:
Transdermal and topical pharmaceutical preparations for humans and animals for the treatment of cardiovascular, viral, bacterial, fungal, inflammatory, circulatory, respiratory, bone, neoplastic, malignant, allergic, convulsant, hypertensive, pain, parasitic, stomach, central nervous system, peripheral nervous system, psychotic, glycemic, muscle or a brain disorder or disease;Human and animal transdermal and topical pharmaceutical drug research and development services;
Categories: TRANSDERMAL TOPICAL PHARMACEUTICAL PREPARATIONS